| Malignant Neoplasm studied in …STUDIED_INderived200 of 20,078show all (up to 200) |
|---|
| → studied in | NCT00027326enrolling by invitation Collection of Blood and Urine From Patients Undergoing Radiation Therapy · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00034216recruiting Collection of Blood From Patients With Cancer · condition mapped CURATED_EXACT · 20,078 trials mapped (5,564 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00068003enrolling by invitation Harvesting Cells for Experimental Cancer Treatments · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00092222Phase 2 · active not recruiting Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00923507recruiting Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL) · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01109394recruiting Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01445288completed Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01633021completed Developing the Family Map: Looking at Communal Coping · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01676805recruiting Tissue Collection for Studies of Lymph Cancer · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Lymphomatoid Granulomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02108028completed Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02595957recruiting Genomic Services Research Program · condition mapped CURATED_EXACT · 20,078 trials mapped (5,564 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02767063Phase 1/Phase 2 · active not recruiting Therapies in Combination or Sequentially With Tyrosine Kinase Inhibitors (TKIs) in Chronic Phase Chronic Myelogenous Leukemia Patients in CCR (ACTIW) · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03494569Phase 1 · suspended Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03560752Phase 1 · active not recruiting CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Transplant · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03623464NA · suspended RCT of Mobile Apps & FitBit v. Usual Care · condition mapped CURATED_EXACT · 20,078 trials mapped (5,564 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04071223Phase 2 · active not recruiting Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Unclassified Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04429191Phase 1 · completed JSP191 Antibody Conditioning Regimen in MDS/AML Subjects Undergoing Allogenic Hematopoietic Stem Cell Transplantation · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04442425completed Machine Learning to Analyze Facial Imaging, Voice and Spoken Language for the Capture and Classification of Cancer/Tumor Pain · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04644770Phase 1 · active not recruiting A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05006716Phase 1/Phase 2 · recruiting A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05007106Phase 2 · completed MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005) · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05015426Phase 1 · active not recruiting Gamma Delta T-cell Infusion for AML at High Risk of Relapse After Allo HCT · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05103358Phase 2 · completed Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05288062Phase 2 · terminated Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (Dexamethasone) for the Treatment of Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05540925completed Vascular Invasion Prediction Via a Multimodal Model Supports Re-staging of Early-stage Hepatocellular Carcinoma · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05554393Phase 2 · recruiting Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial) · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05621291NA · recruiting A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph... · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05664009NA · recruiting The Safety and Efficacy of Redsenol-1 Plus on Cancer-related Fatigue in Adults · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05880160NA · completed Safety of Withdrawal of Pharmacological Treatment for Recovered HER2 Targeted Therapy Related Cardiac Dysfunction · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Therapy-Related Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05932212Phase 2 · terminated AK104 for Recurrent or Metastatic Vulvar Cancer · condition mapped CURATED_EXACT · 20,078 trials mapped (5,564 active) | — | — | Malignant Vulvar Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06124157Phase 2 · recruiting A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL) · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06192758NA · active not recruiting Dose Escalation Study Evaluating Safety of TheraSphere Prostate Cancer (PCa) Device · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06396598NA · completed Electronic Symptom Monitoring Program for Triggered Palliative Referrals in Patients With Thoracic Cancer · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Malignant Thoracic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06484062Phase 1 · recruiting Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06586957Phase 1 · recruiting A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06651229Phase 1 · active not recruiting A Study of JNJ-90189892 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06726161Phase 1/Phase 2 · recruiting Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06902402NA · recruiting Evaluation of Safety and Efficacy of Supportan® Drink · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06904066Phase 1 · recruiting Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06958432Phase 2/Phase 3 · recruiting Node-Sparing Short-Course Radiotherapy Sequential Chemotherapy and PD-1 Inhibitor for Mid/Low pMMR/MSS Rectal Cancer (MODIFI-RC-II) · condition mapped CURATED_EXACT · 20,078 trials mapped (5,564 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07126587NA · completed Healthy Living Anson Study · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07227012Phase 1/Phase 2 · recruiting Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body. · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07305428NA · recruiting Downstaging Unresectable Hepatocellular Carcinoma to Resectable Disease With Combined Immunotherapy and Stereotactic Beamed Radiotherapy: a Pilot Study · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07328516enrolling by invitation Natural History Study of Early Life Exposures in Agriculture (ELEA) · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07346157Phase 1/Phase 2 · recruiting Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07416188Phase 1/Phase 2 · recruiting Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07437950Phase 2 · recruiting Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial) · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07524530Phase 2 · not yet recruiting Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07572136Phase 1 · recruiting Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL) · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07574541Phase 2 · not yet recruiting Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07667400Phase 1/Phase 2 · not yet recruiting Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07691762Phase 3 · not yet recruiting A Study of TACE in Combination With SHR-8068, Adebrelimab, and Bevacizumab Versus TACE in Participants With Incurable Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07704476NA · recruiting EXERT-BC Protein: Protein Supplementation to Improve Body Composition After Treatment for Breast Cancer · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07843433not yet recruiting ImprovINg the TIMEly Diagnosis and Treatment of Cancer and Cardio-metabolic Diseases in People With Mental Disorders: Reducing Health Disparities Through Integrated Care · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07843537Phase 2 · not yet recruiting MINTER Trial: Metal Intervention aNd ThErapy With Radiotherapy In Thoracic Cancer Using Copper Donor Therapy: A Phase 2, Open-Label Study · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Thoracic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07844057Phase 2 · not yet recruiting First-line Treatment in Locally Advanced or Metastastic Small Bowel Adenocarcinoma · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Small Intestinal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07845266Phase 1 · completed Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GKL-006 Injection in Combination With TACE in Unresectable Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07845422NA · recruiting A Study of Music Therapy for Anxiety in People With Cancer · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02458014Phase 2 · completed Blinatumomab in Treating Patients With B-cell Acute Lymphoblastic Leukemia With Minimal Residual Disease · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03516942active not recruiting Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03629171Phase 2 · recruiting Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03702309recruiting Liquid Biopsy Evaluation and Repository Development at Princess Margaret · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03779854Phase 2 · active not recruiting Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Acute Biphenotypic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04123379Phase 2 · active not recruiting Neoadjuvant Nivolumab With CCR2/5-inhibitor or Anti-IL-8) for Non-small Cell Lung Cancer (NSCLC) or Hepatocellular Carcinoma (HCC) · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04267848Phase 3 · recruiting Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO]) · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04594642Phase 1 · active not recruiting A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04750915active not recruiting NIH-AARP Diet and Health Secondary Research Study Based on OH95CN025 Data · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04765241NA · active not recruiting mHealth Physical Activity Intervention for Young Cancer Survivors · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04858334Phase 2 · recruiting APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04981119recruiting Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05136196Phase 2 · recruiting BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05276310Phase 1 · recruiting A Study of IMC-002 in Patients With Advanced Cancer Failed to Standard Therapy · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05327543NA · recruiting Effects of Online Yoga on the Quality of Life of Breast Cancer Patients · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05453903Phase 1 · active not recruiting A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05474846Phase 2/Phase 3 · active not recruiting Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05513742Phase 2 · completed A Study of CTX-009 in Adult Patients With Metastatic Colorectal Cancer · condition mapped CURATED_EXACT · 20,078 trials mapped (5,564 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05564390Phase 2 · recruiting MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial) · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05610163Phase 2/Phase 3 · active not recruiting Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation and Continuing Response · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05673057Phase 1 · completed Study of MP0533 in Patients Acute Myeloid Leukemia or Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05886491Phase 1/Phase 2 · terminated A Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05922930Phase 1/Phase 2 · active not recruiting Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05973344recruiting Understanding and Anticipating Therapeutic and ADverse Responses in Anti-cancer Immune Checkpoint Inhibition Towards a Better Therapeutic Management of Patients · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06052826Phase 2 · recruiting Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06084234Phase 4 · recruiting National Liver Cancer Screening Trial · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06144606Phase 2 · recruiting Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL) · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06317662Phase 2 · recruiting Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06548230Phase 1/Phase 2 · recruiting A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML) · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06618001Phase 1 · active not recruiting A Study of JNJ-89853413 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06618664Phase 3 · recruiting A Clinical Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab Combined With Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma (KYLIN-02) · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06667427NA · recruiting Pilot Study of Management of Facial Paralysis in the Oncologic Patient: Nerve Transfer Techniques to Improve Facial Function and Quality of Life · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06737913Phase 2 · recruiting HAI or IV of Adebrelimab, Combined With Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular Carcinoma · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06768489Phase 1 · recruiting A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06788509Phase 1 · enrolling by invitation A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06820268Phase 1 · recruiting A Study of XS-04 in Patients With Relapsed or Refractory Hematologic Malignancies · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06852222Phase 3 · recruiting A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06979596Phase 2 · recruiting A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015) · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06980038Phase 2 · recruiting Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07093567active not recruiting Opiophobia in Adults With Advanced Cancer · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07105033NA · recruiting Development and Pilot Trial of Focused ACT (FACT) for Patients With Advanced Cancer · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07105046NA · not yet recruiting Facilitators and Barriers to Cancer Treatment Among Texas Residents · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07124000recruiting DESTINY-PANTUMOUR04 · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07211958Phase 3 · recruiting Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07246954NA · recruiting A Chaplain-clinician Led Spiritual Care (PEACE) Intervention on Spiritual/Religious Beliefs Related to Medical Care in Patients With Advanced Cancer: a Pilot Clinical Trial · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07259317Phase 2 · recruiting Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07295951Phase 1 · completed A Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute Leukemia · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07410689NA · recruiting SAFE.AI: Developing and Testing an AI-based Hybrid Chatbot for Financial Empowerment in Rural Cancer Care · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07426757Phase 1 · recruiting An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07489066Phase 2 · recruiting Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07570173Phase 2/Phase 3 · recruiting A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005) · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07600749Phase 1 · recruiting Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001) · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07630974Phase 1/Phase 2 · recruiting A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01) · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07714044recruiting Rutgers University Study of the Genetics of Blood Cancers · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07838714Phase 1 · recruiting Dual-Targeted Umbilical Cord Blood CAR-T Cells Against CD19 and CD22 for the Treatment of Relapsed or Refractory Acute B-Cell Lymphoblastic Leukemia · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07840677Phase 2 · recruiting Tafolecimab Combined With Chemoimmunotherapy as Neoadjuvant Treatment for pMMR/MSS Locally Advanced Colon Cancer · condition mapped CURATED_EXACT · 20,078 trials mapped (5,564 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07841002Phase 1 · not yet recruiting CLL-1-Targeted In Vivo CAR-T Cell Immunotherapy for Relapsed/Refractory Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07841236Phase 2 · recruiting ctDNA-Guided Immunotherapy for dMMR/MSI-H Colon Cancer · condition mapped CURATED_EXACT · 20,078 trials mapped (5,564 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02040376Phase 3 · completed Metformin for Brain Repair in Children With Cranial-Spinal Radiation for Medulloblastoma · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02293954NA · active not recruiting Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02992522Phase 1 · active not recruiting Obinutuzumab, Venetoclax, and Lenalidomide in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Grade 1 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03661307Phase 1/Phase 2 · recruiting Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03739814Phase 2 · recruiting Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Invasive Bladder Lipid-Rich Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03874052Phase 1 · recruiting Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04145141completed National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04181060Phase 3 · recruiting Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04219163Phase 1 · active not recruiting Chimeric Antigen Receptor T-cells for The Treatment of AML Expressing CLL-1 Antigen · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04728893Phase 2 · recruiting Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003) · condition mapped PROBABILISTIC · 20,078 trials mapped (5,564 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04840602Phase 2 · recruiting Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04868799completed Finding New Targets by Proteomic Approaches (InnovRT1) · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Atypical Teratoid/Rhabdoid Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05721053active not recruiting Improving Outcomes for Older Adults Undergoing Radiation Therapy · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05752136Phase 3 · recruiting Preoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal Adenocarcinoma · condition mapped CURATED_EXACT · 20,078 trials mapped (5,564 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05949125Phase 1 · recruiting Phase 1 Study of Allo-RevCAR01-T-CD123 in Patients With Selected CD123 Positive Hematologic Malignancies (1b Dose Expansion) · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06172296Phase 3 · recruiting Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06197672Phase 1 · suspended Chimeric Antigen Receptor T Cell Redirected to Target CD4 Positive Relapsed Refractory Acute Myeloid Leukemia (AML ) as a Bridge to Allogeneic Stem Cell Transplant · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06398457early Phase 1 · recruiting Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06649812Phase 2 · recruiting Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | High Grade B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06714591Phase 1 · terminated Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1 · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06870617active not recruiting Practical Geriatric Assessment (PGA) Implementation Strategies and Correlative Evaluations (PACE-70) · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06871410Phase 1 · recruiting Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06882746Phase 1 · terminated A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06995872Phase 1 · recruiting Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07223463NA · recruiting A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07548450Phase 2 · not yet recruiting Mosunetuzumab in Combination With Pirtobrutinib in Patients With Relapsed or Refractory Waldenstrom Macroglobulinemia (MPOWER) · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07838415recruiting Multimodalomics-based Construction of Spatiotemporal Characteristics of Dynamic Liver Cancer Microenvironment to Characterize the Clinical Application of Immune Mechanisms in Liver Cancer · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07839767recruiting Treatment Selection by 3D Bioprinting Liver Model to Prevent Liver Cancer Recurrence · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07840092recruiting Biomarker Validation for Treatment Efficacy and Recurrence Prediction in Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00242723recruiting Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Thoracic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02392429Phase 2 · active not recruiting FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03015896Phase 1/Phase 2 · completed Nivolumab and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Grade 1 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03873064recruiting Body Mass Index (BMI) and Quality of Life (QoL) in Cancer Patients · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03899155Phase 2 · recruiting Pan Tumor Rollover Study · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03952624completed Patient-Centered Assessment of Symptoms and Outcomes · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04266795Phase 2 · completed A Study of Pevonedistat and Venetoclax Combined With Azacitidine to Treat Acute Myeloid Leukemia (AML) in Adults Unable to Receive Intensive Chemotherapy · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04837547Phase 1 · active not recruiting PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05193721Phase 1 · completed A Clinical Study of the Safety and Tolerability of SHR-1901 in Subjects With Advanced Malignant Tumors · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05290194Phase 2 · withdrawn Radiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine in the Treatment of Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05360160Phase 1/Phase 2 · recruiting A Phase I-II Study Investigating the All-Oral Combination of the Menin Inhibitor SNDX-5613 With Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE) · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05645718Phase 2 · recruiting Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05918692Phase 1 · completed A Phase 1 Study of BMF-500 in Adults With Acute Leukemia · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06337552NA · active not recruiting High-Fermented Food Intervention Among Locally Advanced Rectal Cancer Patients (The FEED Trial) · condition mapped CURATED_EXACT · 20,078 trials mapped (5,564 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06491862recruiting RACE-2L: Real-World Assessment of Clinical Practice and Outcomes in Non-squamous NSCLC After Failure of Platinum-based Chemotherapy in Brazil · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06627647Phase 3 · recruiting A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06915753Phase 1 · recruiting Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07012044Phase 1 · recruiting A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07291076Phase 1/Phase 2 · recruiting A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206) · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07343024recruiting Methods of Identifying Effective Off-Guideline Treatments for Advanced Cancer Patients (CC N-of-1) · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07405164Phase 3 · recruiting Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043) · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07581002Phase 2/Phase 3 · recruiting A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML) · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07788339NA · not yet recruiting Keep Social Randomized Controlled Trial for Young Adults With Cancer · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07822919Phase 1 · recruiting A Study of AWT020 in Participants With Advanced Solid Tumors · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07835737Phase 1/Phase 2 · not yet recruiting Safety and Efficacy of Folic Acid Combined With Atezolizumab and Bevacizumab as First-Line Therapy for Unresectable Hepatocellular Carcinoma · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07836309not yet recruiting TACE in Combination With Tislelizumab and Lenvatinib for Advanced HCC (CHANCE2602) · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07836530Phase 3 · not yet recruiting Study Comparing BGB-B2033 With Sorafenib or Lenvatinib in Relapsed Hepatocellular Carcinoma · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07836712Phase 2 · not yet recruiting Multiple Adjunct Therapies to Improve Immunotherapy Treatment in Patients With Locally Advanced or Metastatic Melanoma or Advanced Hepatocellular Cancer · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07837063not yet recruiting Monitoring Treatment Response With Urine and Serum Metabolome Markers in Patients Treated With Novel Hormone Therapy and Have Either Hormone Sensitive Metastatic Prostate Cancer or Disease Progression on Treatment. · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07837440NA · completed Psychoeducation for Anxiety, Depression, Cognitive Avoidance, and Sense of Coherence in Women With Cancer · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00001163active not recruiting Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00039676active not recruiting Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00339495active not recruiting Prostate Lung Colorectal and Ovarian (PLCO) Cancer Screening Trial · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00339963completed Genome Expression in Lymphoma, Leukemia and Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00923065enrolling by invitation Data Collection, Clinical Care and Interventions in CCR, NCI · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01005654recruiting Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01143480recruiting Study of the Effect of Innate on the Inflammatory Response to Endotoxin · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01857934Phase 2 · completed Therapy for Children With Advanced Stage Neuroblastoma · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02491632Phase 2/Phase 3 · active not recruiting Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03182244Phase 3 · completed A Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase 3 (FLT3) Mutation · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03210714Phase 2 · active not recruiting Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Childhood Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03226704enrolling by invitation Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03251989completed Rare CNS Tumors Outcomes &Risk · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03375320Phase 3 · active not recruiting Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Functioning Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03425565Phase 2 · completed A Study of Pembrolizumab in Patients With Advanced Gynaecological Clear Cell Cancer · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03668223NA · completed The PRISM Intervention: a Multi-site Randomized Controlled Trial for Adolescents and Young Adults With Advanced Cancer · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03839771Phase 3 · active not recruiting A Study of Ivosidenib or Enasidenib in Combination With Induction Therapy and Consolidation Therapy, Followed by Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myedysplastic Syndrome EB2, With an IDH1 or IDH2 Mutation, Respectively, Eligible for Intensive Chemotherapy · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03965689Phase 2 · active not recruiting Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04671667Phase 2 · recruiting Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04708470Phase 1/Phase 2 · completed A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers · condition mapped CURATED_EXACT · 20,078 trials mapped (5,564 active) | — | — | Malignant Vulvar Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05035706early Phase 1 · active not recruiting Anti-Leukemia Immune Responses After Irradiation of Extramedullary Tumors · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05040932Phase 1 · completed Study of YH004 (4-1BB Agonist Antibody) in Advanced or Metastatic Malignancy · condition mapped ALIAS · 20,078 trials mapped (5,564 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05172245Phase 1 · recruiting Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer · condition mapped CURATED_BROADER · 20,078 trials mapped (5,564 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05276973Phase 1 · active not recruiting Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 20,078 trials mapped (5,564 active) | — | — | Primary Peritoneal High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |